Page last updated: 2024-10-29

iotrolan and Hemorrhage, Uterine

iotrolan has been researched along with Hemorrhage, Uterine in 2 studies

iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source

Research Excerpts

ExcerptRelevanceReference
"Iotrolan was investigated as a new contrast medium for hysterosalpingography."1.29[Hysterosalpingography using iotrolan--a new contrast medium]. ( Dons-Jensen, H; Jensen, HJ; Kamal, KM, 1993)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lindequist, S1
Rasmussen, F1
Larsen, C1
Jensen, HJ1
Dons-Jensen, H1
Kamal, KM1

Trials

1 trial available for iotrolan and Hemorrhage, Uterine

ArticleYear
Use of iotrolan versus ethiodized poppy-seed oil in hysterosalpingography.
    Radiology, 1994, Volume: 191, Issue:2

    Topics: Abdominal Pain; Adult; Contrast Media; Ethiodized Oil; Female; Humans; Hysterosalpingography; Infert

1994

Other Studies

1 other study available for iotrolan and Hemorrhage, Uterine

ArticleYear
[Hysterosalpingography using iotrolan--a new contrast medium].
    Aktuelle Radiologie, 1993, Volume: 3, Issue:5

    Topics: Abdominal Pain; Adult; Contrast Media; Female; Humans; Hysterosalpingography; Iodized Oil; Triiodobe

1993